SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-20-317635
Filing Date
2020-12-15
Accepted
2020-12-15 09:22:23
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B3 d87012d424b3.htm 424B3 2232702
2 GRAPHIC g87012g01h45.jpg GRAPHIC 23568
3 GRAPHIC g87012g05k45.jpg GRAPHIC 24082
4 GRAPHIC g87012g08j45.jpg GRAPHIC 25664
5 GRAPHIC g87012g09h74.jpg GRAPHIC 26115
6 GRAPHIC g87012g10n10.jpg GRAPHIC 24624
7 GRAPHIC g87012g13s60.jpg GRAPHIC 25070
8 GRAPHIC g87012g60k45.jpg GRAPHIC 37518
9 GRAPHIC g87012g77o31.jpg GRAPHIC 15422
10 GRAPHIC g87012g90m50.jpg GRAPHIC 32243
  Complete submission text file 0001193125-20-317635.txt   2532887
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-249944 | Film No.: 201388337
SIC: 2834 Pharmaceutical Preparations